You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 29, 2024

CLINICAL TRIALS PROFILE FOR LEVOKETOCONAZOLE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for LEVOKETOCONAZOLE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01838551 ↗ Treatment for Endogenous Cushing's Syndrome Completed Cortendo AB Phase 3 2014-08-01 The primary objectives of this study are to evaluate the clinical responder rate, defined as the proportion of subjects with normal UFC after 6 months of treatment with COR-003 in the Maintenance Phase without dose increase, and to evaluate the range of effective doses in subjects with various levels of hypercortisolism.
NCT03277690 ↗ A Study to Assess the Safety and Efficacy of Levoketoconazole in the Treatment of Endogenous Cushing's Syndrome. Completed Cortendo AB Phase 3 2017-09-26 This is a double-blind, randomized, placebo-controlled withdrawal and rescue/restoration study in subjects with endogenous CS previously treated with single-arm, open-label levoketoconazole that will assess efficacy, safety, tolerability, and pharmacokinetics of levoketoconazole.
NCT03621280 ↗ Open-label Treatment in Cushing's Syndrome Active, not recruiting Cortendo AB Phase 3 2019-01-07 This is a long-term, open-label extension study of levoketoconazole in subjects with endogenous Cushing's Syndrome.
NCT03768388 ↗ Levoketoconazole Food Effect Study in Healthy Subjects Completed Cortendo AB Phase 1 2018-11-30 This is a phase I, randomized, open-label, single-dose, two-period, two-sequence crossover study in healthy male and female subjects to evaluate the effect of food on the PK of levoketoconazole.
NCT03880825 ↗ Drug Interaction Study of Levoketoconazole and Metformin Completed Cortendo AB Phase 1 2019-03-28 This is a phase I, open-label, fixed-sequence drug-drug interaction study to evaluate the effect of levoketoconazole on the single-dose PK of metformin in health subjects.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for LEVOKETOCONAZOLE

Condition Name

Condition Name for LEVOKETOCONAZOLE
Intervention Trials
Endogenous Cushing's Syndrome 2
Healthy Subjects 2
Cushing Disease 1
Cushing Syndrome 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for LEVOKETOCONAZOLE
Intervention Trials
Syndrome 3
Cushing Syndrome 3
Pituitary ACTH Hypersecretion 1
ACTH-Secreting Pituitary Adenoma 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for LEVOKETOCONAZOLE

Trials by Country

Trials by Country for LEVOKETOCONAZOLE
Location Trials
United States 38
Spain 5
Romania 4
Bulgaria 3
Italy 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for LEVOKETOCONAZOLE
Location Trials
Florida 5
Pennsylvania 3
Oregon 3
New York 3
Michigan 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for LEVOKETOCONAZOLE

Clinical Trial Phase

Clinical Trial Phase for LEVOKETOCONAZOLE
Clinical Trial Phase Trials
Phase 3 3
Phase 1 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for LEVOKETOCONAZOLE
Clinical Trial Phase Trials
Completed 5
Active, not recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for LEVOKETOCONAZOLE

Sponsor Name

Sponsor Name for LEVOKETOCONAZOLE
Sponsor Trials
Cortendo AB 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for LEVOKETOCONAZOLE
Sponsor Trials
Industry 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.